Webinar | March 31, 2020

New Paradigm For Clinical Management Systems

Source: Catalyst Clinical Research

The usual approach of adding technology and headcount to manage today’s clinical trials is not sustainable or scalable. In this webinar, Nick Dyer (CEO, Catalyst Clinical Research) discusses the challenges his team has experienced with complex early phase oncology studies, and why they chose Medidata’s CTMS to help Catalyst attain operational success.

Stacey Yount (VP of Product – Trial Management Solutions, Medidata) will also discuss how Rave CTMS delivers expected efficiencies and more importantly, enables you to be effective.

You will learn how to:

  • Cut through the data noise and make smarter decisions
  • Break down the silos and improve collaboration
  • “See” issues and remediate before they become big problems

This paradigm shift enabling Intelligent Oversight provides scalability and flexibility to meet and exceed expectations, now and in the future.

access the Webinar!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Catalyst Clinical Research